iTeos Therapeutics | 4:持股变动声明- Boxer Capital, LLC
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
iTeos Therapeutics | 4:持股变动声明- RA CAPITAL MANAGEMENT, L.P.
iTeos Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Boxer Capital, LLC(8.1%),Boxer Asset Management Inc.(8.1%)等
iTeos Therapeutics | 4:持股变动声明-高管 Gall Matthew
iTeos Therapeutics | 4:持股变动声明-高管 Call Matthew
iTeos Therapeutics | 4:持股变动声明-高管 McGrath Yvonne
iTeos Therapeutics | 4:持股变动声明-高管 Detheux Michel
iTeos Therapeutics | 4:持股变动声明-董事 DeSimone Jill
iTeos Therapeutics | 3:首次持股声明-董事 DeSimone Jill
iTeos Therapeutics | SC 13G:超过5%持股股东披露文件-EcoR1 Capital, LLC(5.4%),Oleg Nodelman(5.4%)等
iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(3.5%),BVF Inc.(3.5%)等
iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(4.17%)
iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(11.9%)
iTeos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Millennium Management LLC(2.7%),Millennium Group Management LLC(2.7%)等
iTeos Therapeutics | 4:持股变动声明-高管 McGrath Yvonne
iTeos Therapeutics | 4:持股变动声明-首席运营官 Call Matthew
iTeos Therapeutics | 4:持股变动声明-首席财务官 Gall Matthew
iTeos Therapeutics | 4:持股变动声明-首席执行官 Detheux Michel
iTeos Therapeutics | 4:持股变动声明-董事 Lee David K
暂无数据